Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Original Research

RMJ. 2021; 46(4): 932-935


Effectiveness the combination therapy of chymotrypsin and dexamethasone vs dexamethasone alone in patients with oral sub mucous fibrosis

Shoaib Ayub, Saaduddin Siddiqui, Syed Kashif Abrar, Muhammad Atif, Raheel Allana, Muhtada Ahmad.

Abstract
Objective: To compare the effectiveness of combination therapy of chymotrypsin and dexamethasone vs dexamethasone alone in patients with oral sub mucous fibrosis.
Methodology: This comparative study trial was conducted in the Department of Oral and Maxillofacial Surgery, Dow University of Health Sciences from November 2019 to April 2020. It included 146 diagnosed patients of oral sub mucous fibrosis (OSMF), equally divided into two groups by lottery method. Group a had 73 patients, treated with intra-lesion injection of combination of chymotrypsin and dexamethasone and group B 73 patients were treated with only dexamethasone. Weekly injections therapy was continued till one month and mouth opening was recorded. On monthly follow-up of both groups without therapy for 3 months, mouth opening was recorded and difference between the two groups was analyzed.
Results: Inter-incisal width (3-5 mm) significantly increased in group A compared to group B suggesting that combination therapy of chymotrypsin and dexamethasone was more effective than dexamethasone therapy (74% vs. 57.5%) with p=0.036.
Conclusion: More consistent results for mouth opening can be expected when oral submucous fibrosis is treated by intralesional injection of combination of chymotrypsin and dexamethasone.

Key words: Oral submucous fibrosis, precancerous condition, restricted mouth opening, steroid, chymotrypsin.






Similar Articles

Full-text options


Latest Statistics about COVID-19
• pubstat.org


Add your Article(s) to Indexes
• citeindex.org






Journal Finder
Covid-19 Trends and Statistics
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
ScopeMed.com
Follow ScopeMed on Twitter
Online Journal Management
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.